Renal denervation modulates angiotensin receptor expression in the renal cortex of rabbits with chronic heart failure

American Journal of Physiology - Renal Physiology

Volumn 300, Issue 1, 2011, Pages

  Clayton, Sarah C ^a   Haack, Karla K V ^a   Zucker, Irving H ^a  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

Angiotensin II; Cardiorenal syndrome; Norepinephrine; Renal sympathetic nerve activity

Indexed keywords

ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN 2 RECEPTOR; NORADRENALIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; EXPERIMENTAL RABBIT; HEART FAILURE; HEART VENTRICLE PACING; KIDNEY BLOOD FLOW; KIDNEY BLOOD VESSEL; KIDNEY CORTEX; KIDNEY DENERVATION; KIDNEY NERVE; KIDNEY VASCULAR RESISTANCE; MALE; MICROVASCULATURE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SMOKE; SYMPATHETIC TONE;

EID: 78651287117     PISSN: 1931857X     EISSN: 15221466     Source Type: Journal    
DOI: 10.1152/ajprenal.00088.2010     Document Type: Article

References (56)

1. Abassi Z, Francis B, Wessale J, Ovcharenko E, Winaver J, Hoffman A. Effects of endothelin receptors ET(A) and ET(B) blockade on renal haemodynamics in normal rats and in rats with experimental congestive heart failure. Clin Sci (Lond) 103 Suppl 48: 245S-248S, 2002.
2. 1-receptor blockade on angiotensin II and adrenergic agonist-induced renal vasoconstrictions in spontaneously hypertensive rats. Acta Physiol 195: 397-404, 2009.
3. Balt JC, Mathy MJ, Nap A, Pfaffendorf M, van Zwieten PA. Effect of the AT1-receptor antagonists losartan, irbesartan, and telmisartan on angiotensin II-induced facilitation of sympathetic neurotransmission in the rat mesenteric artery. J Cardiovasc Pharmacol 38: 141-148, 2001.
4. Barajas L. Innervation of the renal cortex. Fed Proc 37: 1192-1201, 1978.
5. Bencsath P, Fekete MI, Kanyicska B, Szenasi G, Takacs L. Renal excretion of sodium after bilateral renal sympathectomy in the anaesthetized and conscious rat. J Physiol 331: 443-450, 1982.
6. Brewster UC, Setaro JF, Perazella MA. The renin-angiotensin-aldosterone system: cardiorenal effects and implications for renal and cardiovascular disease states. Am J Med Sci 326: 15-24, 2003.
7. Burns KD, Homma T, Harris RC. The intrarenal renin-angiotensin system. Semin Nephrol 13: 13-30, 1993.
8. Chan JS, Wang TT, Zhang SL, Chen X, Carriere S. Catecholamines and angiotensinogen gene expression in kidney proximal tubular cells. Mol Cell Biochem 212: 73-79, 2000.
9. Cheng HF, Becker BN, Burns KD, Harris RC. Angiotensin II upregulates type-1 angiotensin II receptors in renal proximal tubule. J Clin Invest 95: 2012-2019, 1995.
10. Clayton SC, Curry PL, Li Y, Zucker IH. Exercise training and renal denervation attenuate the expression of angiotensin II type 1 and 2 receptors in rabbits with chronic heart failure. FASEB J 22: 159, 2008.
11. Cohn JN, Levine TB, Olivari MT, Garberg V, Lura D, Francis GS, Simon AB, Rector T. Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure. N Engl J Med 311: 819-823, 1984.
12. DiBona GF. Nervous kidney. Interaction between renal sympathetic nerves and the renin-angiotensin system in the control of renal function. Hypertension 36: 1083-1088, 2000.
13. DiBona GF. Peripheral and central interactions between the renin-angiotensin system and the renal sympathetic nerves in control of renal function. Ann NY Acad Sci 940: 395-406, 2001.
14. DiBona GF. Neurogenic regulation of renal tubular sodium reabsorption. Am J Physiol Renal Fluid Electrolyte Physiol 233: F73-F81, 1977.
15. DiBona GF, Kopp UC. Neural control of renal function. Physiol Rev 77: 75-197, 1997.
16. DiBona GF, Sawin LL. Losartan corrects abnormal frequency response of renal vasculature in congestive heart failure. Am J Physiol Heart Circ Physiol 285: H1857-H1863, 2003.
17. Dohadwala MM, Givertz MM. Role of adenosine antagonism in the cardiorenal syndrome. Cardiovasc Ther 26: 276-286, 2008.
18. Du Y, Qiu J, Nelson SH, Wang DH. Regulation of type 1 ANG II receptor in vascular tissue: role of alpha1-adrenoreceptor. Am J Physiol Regul Integr Comp Physiol 273: R1224-R1229, 1997.
19. Eiskjaer H, Bagger JP, Mogensen CE, Schmitz A, Pedersen EB. Enhanced urinary excretion of albumin in congestive heart failure: effect of ACE-inhibition. Scand J Clin Lab Invest 52: 193-199, 1992.
20. Endlich N, Endlich K, Taesch N, Helwig JJ. Culture of vascular smooth muscle cells from small arteries of the rat kidney. Kidney Int 57: 2468-2475, 2000.
21. Gao L, Wang W, Liu D, Zucker IH. Exercise training normalizes sympathetic outflow by central antioxidant mechanisms in rabbits with pacing-induced chronic heart failure. Circulation 115: 3095-3102, 2007.
22. Gonzalez M, Lobos L, Castillo F, Galleguillos L, Lopez NC, Michea L. High-salt diet inhibits expression of angiotensin type 2 receptor in resistance arteries. Hypertension 45: 853-859, 2005. (Pubitemid 40628928)
23. Griendling KK, Minieri CA, Ollerenshaw JD, Alexander RW. Angiotensin II stimulates NADH and NADPH oxidase activity in cultured vascular smooth muscle cells. Circ Res 74: 1141-1148, 1994.
24. Handa RK, Johns EJ. Interaction of the renin-angiotensin system and the renal nerves in the regulation of rat kidney function. J Physiol 369: 311-321, 1985.
25. Harrison DG, Cai H, Landmesser U, Griendling KK. Interactions of angiotensin II with NAD(P)H oxidase, oxidant stress and cardiovascular disease. J Renin Angiotensin Aldosterone Syst 4: 51-61, 2003.
26. Harrison-Bernard LM, El-Dahr SS, O'Leary DF, Navar LG. Regulation of angiotensin II type 1 receptor mRNA and protein in angiotensin II-induced hypertension. Hypertension 33: 340-346, 1999.
27. Hillege HL, Girbes AR, de Kam PJ, Boomsma F, de Zeeuw D, Charlesworth A, Hampton JR, van Veldhuisen DJ. Renal function, neurohormonal activation, and survival in patients with chronic heart failure. Circulation 102: 203-210, 2000.
28. Hillege HL, Nitsch D, Pfeffer MA, Swedberg K, McMurray JJ, Yusuf S, Granger CB, Michelson EL, Ostergren J, Cornel JH, de Zeeuw D, Pocock S, van Veldhuisen DJ. Renal function as a predictor of outcome in a broad spectrum of patients with heart failure. Circulation 113: 671-678, 2006.
29. Holdaas H, DiBona GF, Kiil F. Effect of low-level renal nerve stimulation on renin release from nonfiltering kidneys. Am J Physiol Renal Fluid Electrolyte Physiol 241: F156-F161, 1981. (Pubitemid 11044064)
30. Jones ES, Vinh A, McCarthy CA, Gaspari TA, Widdop RE. AT2 receptors: functional relevance in cardiovascular disease. Pharmacol Ther 120: 292-316, 2008.
31. Katz SD, Schwarz M, Yuen J, LeJemtel TH. Impaired acetylcholine-mediated vasodilation in patients with congestive heart failure. Role of endothelium-derived vasodilating and vasoconstricting factors. Circulation 88: 55-61, 1993.
32. Kost CK Jr, Jackson EK. Enhanced renal angiotensin II subtype 1 receptor responses in the spontaneously hypertensive rat. Hypertension 21: 420-431, 1993.
33. Krum H, Iyngkaran P, Lekawanvijit S. Pharmacologic management of the cardiorenal syndrome in heart failure. Curr Heart Fail Rep 6: 105-111, 2009.
34. Li H, Gao Y, Grobe JL, Raizada MK, Katovich MJ, Sumners C. Potentiation of the antihypertensive action of losartan by peripheral overexpression of the ANG II type 2 receptor. Am J Physiol Heart Circ Physiol 292: H727-H735, 2007.
35. Lindley TE, Infanger DW, Rishniw M, Zhou Y, Doobay MF, Sharma RV, Davisson RL. Scavenging superoxide selectively in mouse forebrain is associated with improved cardiac function and survival following myocardial infarction. Am J Physiol Regul Integr Comp Physiol 296: R1-R8, 2009.
36. Liu D, Gao L, Roy SK, Cornish KG, Zucker IH. Role of oxidant stress on AT1 receptor expression in neurons of rabbits with heart failure and in cultured neurons. Circ Res 103: 186-193, 2008.
37. Liu JL, Kulakofsky J, Zucker IH. Exercise training enhances baroreflex control of heart rate by a vagal mechanism in rabbits with heart failure. J Appl Physiol 92: 2403-2408, 2002.
38. Lloyd-Jones D, Adams R, Carnethon M, De Simone G, Ferguson TB, Flegal K, Ford E, Furie K, Go A, Greenlund K, Haase N, Hailpern S, Ho M, Howard V, Kissela B, Kittner S, Lackland D, Lisabeth L, Marelli A, McDermott M, Meigs J, Mozaffarian D, Nichol G, O'Donnell C, Roger V, Rosamond W, Sacco R, Sorlie P, Stafford R, Steinberger J, Thom T, Wasserthiel-Smoller S, Wong N, Wylie-Rosett J, Hong Y. Heart disease and stroke statistics - 2009 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 119: 480-486, 2009.
39. 2 receptor subtypes in the rat kidney. Am J Physiol Renal Physiol 277: F437-F446, 1999.
40. Mogil RA, Itskovitz HD, Russell JH, Murphy JJ. Renal innervation and renin activity in salt metabolism and hypertension. Am J Physiol 216: 693-697, 1969.
41. Mousa TM, Gao L, Cornish KG, Zucker IH. Effects of angiotensin II on autonomic components of nasopharyngeal stimulation in male conscious rabbits. J Appl Physiol 98: 1607-1611, 2005.
42. Nozawa T, Igawa A, Fujii N, Kato B, Yoshida N, Asanoi H, Inoue H. Effects of long-term renal sympathetic denervation on heart failure after myocardial infarction in rats. Heart Vessels 16: 51-56, 2002.
43. Otsuka S, Sugano M, Makino N, Sawada S, Hata T, Niho Y. Interaction of mRNAs for angiotensin II type 1 and type 2 receptors to vascular remodeling in spontaneously hypertensive rats. Hypertension 32: 467-472, 1998.
44. Patel J, Heywood JT. Management of the cardiorenal syndrome in heart failure. Curr Cardiol Rep 8: 211-216, 2006.
45. Petersson M, Friberg P, Eisenhofer G, Lambert G, Rundqvist B. Long-term outcome in relation to renal sympathetic activity in patients with chronic heart failure. Eur Heart J 26: 906-913, 2005. (Pubitemid 40676571)
46. Phillips JK. Pathogenesis of hypertension in renal failure: role of the sympathetic nervous system and renal afferents. Clin Exp Pharmacol Physiol 32: 415-418, 2005.
47. Raizada MK, Sumners C. Lack of alpha-1-adrenergic receptor-mediated downregulation of angiotensin II receptors in neuronal cultures from spontaneously hypertensive rat brain. Mol Cell Biochem 91: 111-115, 1989.
48. Rajapakse NW, Eppel GA, Widdop RE, Evans RG. ANG II type 2 receptors and neural control of intrarenal blood flow. Am J Physiol Regul Integr Comp Physiol 291: R1669-R1676, 2006.
49. Roux S, Breu V, Ertel SI, Clozel M. Endothelin antagonism with bosentan: a review of potential applications. J Mol Med 77: 364-376, 1999.
50. Shlipak MG, Massie BM. The clinical challenge of cardiorenal syndrome. Circulation 110: 1514-1517, 2004.
51. Szalay L, Colindres RE, Jackson R, Gottschalk CW. Effects of chronic renal denervation in conscious restrained rats. Int Urol Nephrol 18: 3-18, 1986.
52. Wallin BG, Thompson JM, Jennings GL, Esler MD. Renal noradrenaline spillover correlates with muscle sympathetic activity in humans. J Physiol 491: 881-887, 1996.
53. Wang TT, Wu XH, Zhang SL, Chan JS. Molecular mechanism(s) of action of norepinephrine on the expression of the angiotensinogen gene in opossum kidney cells. Kidney Int 54: 785-795, 1998.
54. Wei SG, Yu Y, Zhang ZH, Weiss RM, Felder RB. Mitogen-activated protein kinases mediate upregulation of hypothalamic angiotensin II type 1 receptors in heart failure rats. Hypertension 52: 679-686, 2008.
55. Westermann D, Riad A, Richter U, Jager S, Savvatis K, Schuchardt M, Bergmann N, Tolle M, Nagorsen D, Gotthardt M, Schultheiss HP, Tschope C. Enhancement of the endothelial NO synthase attenuates experimental diastolic heart failure. Basic Res Cardiol 104: 499-509, 2009.
56. Wilson DR, Honrath U, Sole M. Effect of acute and chronic renal denervation on renal function after release of unilateral ureteral obstruction in the rat. Can J Physiol Pharmacol 57: 731-737, 1979. (Pubitemid 9247357)